ReviewJournal of gastrointestinal cancer2026

Perioperative Circulating Tumor DNA in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma: Molecular Residual Disease, Recurrence Prediction, and a Trial-Ready Framework for Treatment Adaptation.

Tamotsu Sagawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.